Differential expression of Epstein-Barr virus-encoded RNA and several tumor-related genes in various types of nasopharyngeal epithelial lesions and nasopharyngeal carcinoma using tissue microarray analysis

Human Pathology

Volumn 37, Issue 5, 2006, Pages 593-605

  Fan, Song Qing ^a,b   Ma, Jian ^a   Zhou, Jie ^a   Xiong, Wei ^a   Xiao, Bing Yi ^a   Zhang, Wen Ling ^a   Tan, Chen ^a   Li, Xiao Ling ^a   Shen, Shou Rong ^c   Zhou, Ming ^a   Zhang, Qiu Hong ^a   Ou, Yang Jue ^a   Zhuo, Hou De ^a   Fan, Songquing ^d   Zhou, Yan Hong ^a   Li, Gui Yuan ^a  

^a Central South University   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

^d NONE

Author keywords

Carcinogenesis; Epstein Barr virus; Nasopharyngeal carcinoma; Tissue microarray

Indexed keywords

PROTEIN BCL 2; PROTEIN P16; PROTEIN P21; PROTEIN P27; PROTEIN P53; VIRUS RNA;

ARTICLE; CARCINOGENESIS; CELL STRUCTURE; CLUSTER ANALYSIS; CONFIDENCE INTERVAL; GENE OVEREXPRESSION; GENETICS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; NASOPHARYNX CARCINOMA; PHARYNX DISEASE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STATISTICAL ANALYSIS; TISSUE MICROARRAY;

ADENOCARCINOMA; EPITHELIAL CELLS; HUMANS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; NASOPHARYNGEAL NEOPLASMS; NEOPLASM PROTEINS; RNA, VIRAL; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 33646125837     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2006.01.010     Document Type: Article

References (43)

1. Yu M.C., and Yuan J.M. Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol 12 (2002) 421-429
2. Zong Y.S., Zhong B.L., Liang Y.J., et al. Advancement of studying the biological characteristics of nasopharyngeal carcinogenesis. Ai Zheng 21 (2002) 686-695 [in Chinese]
3. Li Zq., Chen J.J., and Li W.J. Early detection of nasopharyngeal carcinoma (NPC) and nasopharyngeal mucosal hyperplastic lesions (NPHL) with its relationship to carcinomatous change. In: Prasad U., Ablashi D.V., and Levine pH. (Eds). Nasopharyngeal carcinoma-current concepts (1983), University of Malaysia Press, Kuala Lumpur, Malaysia 17-23
4. Pathmanathan R., Prasad U., Sadler R., et al. Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Engl J Med 333 (1995) 693-698
5. Chan A.S., To K.F., Lo K.W., et al. High frequency of chromosome 3p deletion in histologically normal nasopharyngeal epithelia from southern Chinese. Cancer Res 60 (2000) 5365-5370
6. Spano J.P., Busson P., Atlan D., et al. Nasopharyngeal carcinomas: an update. Eur J Cancer 39 (2003) 2121-2135
7. Pak M.W., To K.F., Lo Y.M., et al. Nasopharyngeal carcinoma in situ (NPCIS)-pathologic and clinical perspectives. Head Neck 24 (2002) 989-995
8. Lo K.W., Teo P.M., Hui A.B., et al. High resolution allelotype of microdissected primary nasopharyngeal carcinoma. Cancer Res 60 (2000) 3348-3353
9. Makitie A.A., MacMillan C., Ho J., et al. Loss of p16 expression has prognostic significance in human nasopharyngeal carcinoma. Clin Cancer Res 9 (2003) 2177-2184
10. Chan A.S., To K.F., Lo K.W., et al. Frequent chromosome 9p losses in histologically normal nasopharyngeal epithelia from southern Chinese. Int J Cancer 102 (2002) 300-303
11. Kwong J., Lo K.W., To K.F., et al. Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma. Clin Cancer Res 8 (2002) 131-137
12. Huang D.P., and Lo K.W. Aetiological factors and pathogenesis. In: van Hasselt G.A., and Gibb A.G. (Eds). Nasopharyngeal carcinoma. 2nd ed. (1999), The Chinese University Press, Hong Kong 31-60
13. Li A.A., Ng E., Shi W., et al. Potential efficacy of p16 gene therapy for EBV-positive nasopharyngeal carcinoma. Int J Cancer 110 (2004) 452-458
14. Chan A.T., Teo P.M., and Johnson P.J. Nasopharyngeal carcinoma. Ann Oncol 13 (2002) 1007-1015
15. Yang H.J., Cho Y.J., Kim H.S., et al. Association of p53 and BCL-2 expression with Epstein-Barr virus infection in the cancers of head and neck. Head Neck 23 (2001) 629-636
16. Baba Y., Tsukuda M., Mochimatsu I., et al. Reduced expression of p16 and p27 proteins in nasopharyngeal carcinoma. Cancer Detect Prev 25 (2001) 414-419
17. Gleich L.L., and Salamone F.N. Molecular genetics of head and neck cancer. Cancer Control 9 (2002) 369-378
18. Sheu L.F., Chen A., Meng C.L., et al. Analysis of bcl-2 expression in normal, inflamed, dysplastic nasopharyngeal epithelia, and nasopharyngeal carcinoma: association with p53 expression. Hum Pathol 28 (1997) 556-562
19. Sun Y., Hildesheim A., Lanier A.E., et al. No point mutation but decreased expression of the p16/MTS1 tumor suppressor gene in nasopharyngeal carcinomas. Oncogene 10 (1995) 785-788
20. Hwang C.F., Su C.Y., Huang S.C., et al. Low expression levels of p27 correlate with loco-regional recurrence in nasopharyngeal carcinoma. Cancer Lett 189 (2003) 231-236
21. Coutinho C.M., Bassini A.S., Gutierrez L.G., et al. Genetic alterations in Ki-ras and Ha-ras genes in juvenile nasopharyngeal angiofibromas and head and neck cancer. Sao Paulo Med J 117 (1999) 113-120
22. Viola M.V., Fromowitz F., Oravez S., et al. Expression of ras oncogene p21 in prostate cancer. N Engl J Med 314 (1986) 133-137
23. Lu Q.L., Elia G., Lucas S., and Thomas J.A. Bcl-2 proto-oncogene expression in Epstein-Barr-virus-associated nasopharyngeal carcinoma. Int J Cancer 53 (1993) 29-35
24. Tsai S.T., Jin Y.T., Leung H.W., et al. Bcl-2 and proliferating cell nuclear antigen (PCNA) expression correlates with subsequent local recurrence in nasopharyngeal carcinomas. Anticancer Res 18 (1998) 2849-2854
25. Tamura M., Gu J., Tran H., and Yamada K.M. PTEN gene and integrin signaling in cancer. J Natl Cancer Inst 91 (1999) 1820-1928
26. Fenic I., Franke F., Failing K., et al. Expression of PTEN in malignant and non-malignant human prostate tissues: comparison with p27 protein expression. J Pathol 203 (2004) 559-566
27. Halvorsen O.J., Haukaas S.A., and Akslen L.A. Combined loss of PTEN and p27 expression is associated with tumor cell proliferation by Ki-67 and increased risk of recurrent disease in localized prostate cancer. Clin Cancer Res 9 (2003) 1474-1479
28. Kononen J., Bubendorf L., Kallioniemi A., et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4 (1998) 844-847
29. Kallioniemi O.P., Wagne U., Kononen J., and Saute G. Tissue microarray technology for high-throughput molecular profiling of cancer. Hum Mol Genet 10 (2001) 657-662
30. Liu C.L., Prapong W., Natkunam Y., et al. Software tools for high-throughput analysis and archiving of immunohistochemistry staining data obtained with tissue microarrays. Am J Pathol 161 (2002) 1557-1565
31. Zhang L., Fang Y., Huang B., et al. Rapid tissue microarray assay of p16 protein expression for different stage nasopharyngeal carcinoma. Zhonghua Bing Li Xue Za Zhi 31 (2002) 132-134 [in Chinese]
32. Shanmugaratnam K. Histological typing of tumours of the upper respiratory tract and ear. World Health Organization International Histological Classification of Tumours. 2nd ed. (1991), Springer-Verlag, Berlin 32-34
33. 5th International Union Against Cancer (UICC) Classification. TNM Classification of Malignant Tumours. 5th ed. (1997), Springer Verlag, Germany
34. Chu P.G., Chang K.L., Chen Y.Y., et al. No significant association of Epstein-Barr virus infection with invasive breast carcinoma. Am J Pathol 159 (2001) 571-578
35. Lee E.S., Locker J., Nalesnik M., et al. The association of Epstein-Barr virus with smooth-muscle tumors occurring after organ transplantation. N Engl J Med 332 (1995) 19-25
36. Lavertu P., Adelstein D.J., Myles J., and Secic M. P53 and Ki-67 as outcome predictors for advanced squamous cell cancers of the head and neck treated with chemoradiotherapy. Laryngoscope 111 (2001) 1878-1892
37. Ohno Y., Ohno S., Suzuki N., et al. Role of cyclooxygenase-2 in immunomodulation and prognosis of endometrial carcinoma. Int J Cancer 114 (2005) 696-701
38. Niedobitek G. Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma. Mol Pathol 53 (2000) 248-254
39. Sarac S., Akyol M.U., Kanbur B., et al. Bcl-2 and LMP1 expression in nasopharyngeal carcinomas. Am J Otolaryngol 22 (2001) 377-382
40. Ma B.B., Poon T.C., To K.F., et al. Prognostic significance of tumor angiogenesis, Ki 67, p53 oncoprotein, epidermal growth factor receptor and HER2 receptor protein expression in undifferentiated nasopharyngeal carcinoma-a prospective study. Head Neck 25 (2003) 864-872
41. Taniyama K., Goodison S., Ito R., et al. PTEN expression is maintained in sporadic colorectal tumours. J Pathol 194 (2001) 341-348
42. Mai S., Zong Y., Zhang M., et al. Detection of Epstein-Barr virus DNA in plasma/serum: a useful serological indicator for diagnosis of nasopharyngeal carcinoma. Chin Med J 11 (2002) 1895-1897
43. Schneider J., Gonzalez-Roces S., Pollan M., et al. Expression of LRP and MDR1 in locally advanced breast cancer predicts axillary node invasion at the time of rescue mastectomy after induction chemotherapy. Breast Cancer Res 3 (2001) 183-191